Quantitative Systematic Strategies’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,881
Closed -$565K 732
2020
Q4
$565K Buy
+20,881
New +$537K 0.08% 366
2018
Q2
Sell
-17,386
Closed -$270K 747
2018
Q1
$270K Sell
17,386
-12,162
-41% -$217K 0.06% 484
2017
Q4
$558K Buy
+29,548
New +$655K 0.14% 252
2017
Q3
Sell
-27,395
Closed -$879K 520
2017
Q2
$879K Buy
27,395
+19,973
+269% +$656K 0.22% 146
2017
Q1
$257K Buy
+7,422
New +$265K 0.07% 288
2016
Q4
Sell
-6,144
Closed -$211K 396
2016
Q3
$211K Buy
+6,144
New +$215K 0.08% 323
2016
Q1
Sell
-16,779
Closed -$618K 659
2015
Q4
$618K Buy
+16,779
New +$607K 0.17% 162

Other funds holding ACH

Quantitative Systematic Strategies's ACH Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Accendra Health (ACH) in Q1 2021, closing a stake of 20,881 shares — an estimated $565K sold.

Quantitative Systematic Strategies first reported a position in ACH in Q4 2015 and held it in 7 quarters. The position peaked at $879K in Q2 2017. 253 funds tracked by Wall St. Rank hold ACH as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Accendra Health position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 20,881 Accendra Health shares in Q1 2021, an estimated $565K.
  • Quantitative Systematic Strategies first reported a position in Accendra Health in Q4 2015 and held it in 7 quarters.
  • Quantitative Systematic Strategies's Accendra Health position peaked at $879K in Q2 2017.
  • 253 funds tracked by Wall St. Rank held Accendra Health as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.